Microalgae-based hydrogel drug delivery system for treatment of gouty arthritis with alleviated colchicine side effects
Gouty arthritis (GA) is a type of inflammatory arthritis caused by the deposition of monosodium urate crystals. Current clinical therapies fail to simultaneously reduce uric acid (UA) levels and alleviate inflammation. Previous studies have demonstrated that Euglena (Eug) polysaccharides can effecti...
Saved in:
| Main Authors: | Xiaoyang Liu, Jia Dong, Zhongshu Wu, Jiarong Cui, Yixin Zheng, Min Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-10-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X25002154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meridian-Sinew Release Therapy as an adjunctive treatment for gouty arthritis: a systematic review and meta-analysis
by: Xia Zhou, et al.
Published: (2025-08-01) -
Mechanistic Study on the Therapeutic Effects of Juanbi Lijieqing Formula in a Rat Model of Gouty Arthritis with Hyperuricemia
by: Lu Y, et al.
Published: (2025-06-01) -
Gouty arthritis: An approach for general practice
by: M. Tikly, et al.
Published: (2013-08-01) -
Uric Acid, Colchicine and Chronic Inflammatory Diseases: A Cardiovascular Perspective
by: Alessia Alunno, et al.
Published: (2025-06-01) -
Phellodendrine chloride alleviates gouty arthritis through IL-6/STAT3 signaling pathway
by: Yu-yao Qin, et al.
Published: (2025-07-01)